Health Care [ 3/12 ] | Biotechnology [ 26/74 ]
NASDAQ | Common Stock
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development.
The company operates through two segments, Biopharmaceutical and Strategic Investments.
Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models.
The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices.
In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property.
The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024.
Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 12, 24 | -4.17 Decreased by -113.83% | -3.90 Decreased by -6.92% |
| Aug 14, 24 | -5.20 Increased by +42.83% | -3.90 Decreased by -33.33% |
| May 14, 24 | -3.25 Increased by +80.44% | -3.25 |
| Mar 29, 24 | -9.75 Increased by +19.61% | -9.10 Decreased by -7.14% |
| Nov 15, 23 | -1.95 Increased by +73.91% | -9.10 Increased by +78.57% |
| Aug 11, 23 | -9.10 Increased by +5.22% | - |
| May 18, 23 | -16.61 Decreased by -60.18% | - |
| Nov 14, 22 | -12.13 Increased by +49.15% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 0.00 Decreased by N/A% | -3.83 M Decreased by -261.11% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -3.11 M Increased by +43.32% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -1.90 M Decreased by N/A% | Decreased by N/A% - |
| Dec 31, 23 | 0.00 - | -1.32 M - | Decreased by N/A% - |
| Sep 30, 23 | 0.00 - | -1.06 M - | Decreased by N/A% - |
| Jun 30, 23 | 0.00 - | -5.49 M - | Decreased by N/A% - |
| Mar 31, 23 | N/A - | N/A - | - - |